Clinical Trials Browser

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01754987 2025-05-04

A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective

Phase 1/2 Completed

5 enrolled 7 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT03058289 2025-02-27

IT-01

Phase 1/2 Completed

111 enrolled 21 charts

BreastGastrointestinalHead & NeckLymphoidSarcomaThoracic

Diabetes Mellitus, Insulin-Dependent, 12, Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Colonic Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT03602079 2023-08-03

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Phase 1/2 Completed

49 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Laryngeal Neoplasms, Lip Neoplasms, Liver Neoplasms, Lung Neoplasms, Mouth Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Stomach Neoplasms, Tongue Neoplasms, Tonsillar Neoplasms, Urologic Neoplasms, Carcinoma, Mucoepidermoid, Cholangiocarcinoma, Rare Diseases

NCT02795429 2023-07-03

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Phase 1/2 Completed

89 enrolled 37 charts

Gastrointestinal

Liver Neoplasms

NCT01752920 2023-06-05

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

Phase 1/2 Completed

119 enrolled 15 charts

Gastrointestinal

Biliary Tract Neoplasms, Liver Neoplasms, Neoplasms, Cholangiocarcinoma

NCT00867321 2022-04-19

Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Phase 1/2 Completed

24 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00374660 2021-12-08

Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors

Phase 1/2 Completed

63 enrolled

Gastrointestinal

Liver Neoplasms

NCT02291133 2021-07-23

ECT-HCC

Phase 1/2 Completed

25 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

NCT00543777 2021-04-13

Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease

Phase 1/2 Completed

44 enrolled 3 charts

Gastrointestinal

Fatty Liver, Liver Cirrhosis, Liver Diseases, Liver Neoplasms

NCT02082210 2020-12-19

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

Phase 1/2 Completed

97 enrolled 20 charts

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Liver Neoplasms

NCT01264705 2020-11-12

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

Phase 1/2 Completed

47 enrolled 10 charts

Gastrointestinal

Fibrosis, Gastrointestinal Neoplasms, Hepatitis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT00152906 2020-08-14

Stereotactic Radiotherapy (SRT) Liver (COLD 1)

Phase 1/2 Completed

140 enrolled

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT00005629 2020-08-03

Vaccine Therapy in Treating Patients With Liver Cancer

Phase 1/2 Completed

6 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00022334 2020-08-03

Vaccine Therapy in Treating Patients With Liver Cancer

Phase 1/2 Completed

33 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03183219 2020-07-13

Safety and Efficiency of γδ T Cell Against Liver Cancer

Phase 1/2 Completed

30 enrolled

Gastrointestinal

Liver Neoplasms

NCT02541370 2019-12-17

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

Phase 1/2 Completed

20 enrolled

BreastCNSGastrointestinalGynecologicOther hematologic neoplasm

Brain Neoplasms, Breast Neoplasms, Leukemia, Lymphoid, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT01853618 2019-12-10

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Phase 1/2 Completed

61 enrolled 18 charts

Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT02843802 2019-09-12

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

Phase 1/2 Completed

30 enrolled

Gastrointestinal

Liver Neoplasms

NCT00777894 2019-05-15

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase 1/2 Completed

18 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01306058 2019-01-23

Sorafenib and TRC105 in Hepatocellular Cancer

Phase 1/2 Completed

27 enrolled 32 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Liver Neoplasms, Experimental, Adenoma, Liver Cell

NCT02191878 2019-01-16

Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma

Phase 1/2 Completed

43 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00077142 2018-10-31

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Phase 1/2 Completed

37 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00149396 2018-04-24

Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

Phase 1/2 Completed

32 enrolled 17 charts

Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00516165 2017-02-07

RAD001 in Advanced Hepatocellular Carcinoma

Phase 1/2 Completed

28 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00059865 2016-12-07

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Phase 1/2 Completed

68 enrolled

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms

NCT02545556 2016-08-29

Liver Cancer HepaSphere Combined With Cryosurgery

Phase 1/2 Completed

60 enrolled

Gastrointestinal

Liver Neoplasms

NCT02425735 2016-07-19

Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer

Phase 1/2 Completed

40 enrolled

Gastrointestinal

Liver Neoplasms

NCT02447263 2016-02-25

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer

Phase 1/2 Completed

87 enrolled

Gastrointestinal

Liver Neoplasms

NCT02449109 2016-02-25

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma

Phase 1/2 Completed

60 enrolled

Gastrointestinal

Liver Neoplasms

NCT02338778 2015-09-10

Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient

Phase 1/2 Completed

20 enrolled

Gastrointestinal

Liver Neoplasms

NCT01738217 2015-07-08

HEPATOFLUO

Phase 1/2 Completed

48 enrolled

Gastrointestinal

Liver Neoplasms

NCT02089919 2015-06-03

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

Phase 1/2 Completed

40 enrolled

Gastrointestinal

Liver Neoplasms

NCT00493883 2015-05-13

Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors

Phase 1/2 Completed

81 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT01213030 2012-09-25

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Phase 1/2 Completed

12 enrolled

GastrointestinalHead & NeckThoracic

Hypoxia, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms

NCT00614913 2012-08-20

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

Phase 1/2 Completed

76 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00057980 2012-06-11

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

Phase 1/2 Completed

8 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00021047 2012-03-08

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Phase 1/2 Completed

CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Bile Duct Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00187109 2008-04-10

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

Phase 1/2 Completed

40 enrolled

CNSClassical hematologyGastrointestinalSarcoma

Jacobs syndrome, Liver Neoplasms, Neoplasms, Germ Cell and Embryonal, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma, Thrombocytopenia

NCT00122876 2007-12-07

Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Phase 1/2 Completed

25 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00076609 2007-03-28

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Phase 1/2 Completed

31 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00178243 2006-09-08

Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation

Phase 1/2 Completed

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT00234182 2005-12-01

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

Phase 1/2 Completed

84 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Recurrence

NCT00041808 2005-06-24

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Phase 1/2 Completed

20 enrolled

BreastDermatologicGastrointestinalSarcomaThoracic

Breast Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Gastrointestinal Stromal Tumors

Clinical Trials

RELATIVITY-106

A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective

IT-01

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors

ECT-HCC

Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

Stereotactic Radiotherapy (SRT) Liver (COLD 1)

Vaccine Therapy in Treating Patients With Liver Cancer

Vaccine Therapy in Treating Patients With Liver Cancer

Safety and Efficiency of γδ T Cell Against Liver Cancer

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

Tremelimumab With Chemoembolization or Ablation for Liver Cancer

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Sorafenib and TRC105 in Hepatocellular Cancer

Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

RAD001 in Advanced Hepatocellular Carcinoma

Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer

Liver Cancer HepaSphere Combined With Cryosurgery

Safety and Efficiency of γδ T Cell Against Hepatocellular Liver Cancer

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Cancer

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma

Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma Patient

HEPATOFLUO

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver